Disease | pyelonephritis |
Phenotype | C0155866|inhalational anthrax |
Sentences | 1 |
PubMedID- 23741232 | Currently, fqs that are approved by the u.s. food and drug administration (fda) for use in children include ciprofloxacin for the treatment of inhalation anthrax, complicated urinary tract infections, and pyelonephritis along with levofloxacin for inhalational anthrax15,18). |
Page: 1